Company Badge
USPTO Data Jan 1 1976 - Nov 10 2026
8 Patents
#20 in Cranbury, NJ
#1,350 in New Jersey
#36,017 in US
Rafael Pharmaceuticals, Inc.
Forward Citations = 18
7 inventors:
Cranbury, NJ, United States of America
Rafael Pharmaceuticals, Inc.
Calculating rank
% Expired Patents = 37.5
EPO Patents = 2
Trademarks = 3
Forward Citations = 18
Loading Chart...
Loading Chart...
7 inventors (with patents filed for the assignee):
Robert J Rodriguez (8 out of 15 patents)
Robert G L Shorr (5 out of 16 patents)
Rajinder Bhasin (5 out of 8 patents)
4. Lakmal Boteju (3 out of 6 patents)
5. Thomas Kwok (3 out of 7 patents)
6. James Marecek (3 out of 3 patents)
7. Paul M Bingham (3 out of 7 patents)
8. Robert G Shorr (3 out of 34 patents)
9. Lakmal W Boteju (1 patent)
8 patents:
Company Overview
Rafael Pharmaceuticals, Inc. is a clinical-stage, precision oncology therapeutics company targeting cancer metabolism. Their lead product candidate, CPI-613, is being evaluated in multiple Phase 1, 2, and 3 clinical trials for the treatment of various cancers. With a focus on developing innovative therapies for hard-to-treat cancers, Rafael Pharmaceuticals is committed to improving patient outcomes and quality of life.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Rafael Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/rafael-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
2 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]